IL42995A - Difluoromethylene substituted prostaglandin derivatives and their preparation - Google Patents

Difluoromethylene substituted prostaglandin derivatives and their preparation

Info

Publication number
IL42995A
IL42995A IL42995A IL4299573A IL42995A IL 42995 A IL42995 A IL 42995A IL 42995 A IL42995 A IL 42995A IL 4299573 A IL4299573 A IL 4299573A IL 42995 A IL42995 A IL 42995A
Authority
IL
Israel
Prior art keywords
preparation
prostaglandin derivatives
substituted prostaglandin
difluoromethylene
difluoromethylene substituted
Prior art date
Application number
IL42995A
Other languages
English (en)
Other versions
IL42995A0 (en
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of IL42995A0 publication Critical patent/IL42995A0/xx
Publication of IL42995A publication Critical patent/IL42995A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/516—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL42995A 1972-09-08 1973-08-15 Difluoromethylene substituted prostaglandin derivatives and their preparation IL42995A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28733372A 1972-09-08 1972-09-08
US379127A US3867423A (en) 1972-09-08 1973-07-13 Difluoromethylene substituted prostaglandin derivatives

Publications (2)

Publication Number Publication Date
IL42995A0 IL42995A0 (en) 1973-11-28
IL42995A true IL42995A (en) 1978-03-10

Family

ID=26964400

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42995A IL42995A (en) 1972-09-08 1973-08-15 Difluoromethylene substituted prostaglandin derivatives and their preparation

Country Status (13)

Country Link
US (1) US3867423A (de)
JP (1) JPS4992055A (de)
AT (1) AT340071B (de)
CA (1) CA1041496A (de)
CH (4) CH596167A5 (de)
DE (1) DE2344740A1 (de)
ES (1) ES418575A1 (de)
FR (1) FR2198754B1 (de)
GB (1) GB1414881A (de)
HK (1) HK75276A (de)
IL (1) IL42995A (de)
MY (1) MY7700075A (de)
NL (1) NL7312390A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5120803U (de) * 1974-07-31 1976-02-16
US4001295A (en) * 1975-06-23 1977-01-04 Syntex (U.S.A.) Inc. 11,12-difluoromethylene substituted prostanoic and prost-5-cis-enoic acid derivatives
US4188329A (en) * 1975-09-08 1980-02-12 Abbott Laboratories Intermediates for the preparation of prostaglandins and prostaglandin analogs from a mold metabolite
EP0329184A3 (de) * 1988-02-19 1990-05-23 Neorx Corporation Antimere und antimere Konjugation

Also Published As

Publication number Publication date
IL42995A0 (en) 1973-11-28
JPS4992055A (de) 1974-09-03
AU5974773A (en) 1975-03-06
CH595342A5 (de) 1978-02-15
FR2198754A1 (de) 1974-04-05
FR2198754B1 (de) 1976-09-03
GB1414881A (en) 1975-11-19
ES418575A1 (es) 1977-05-01
AT340071B (de) 1977-11-25
NL7312390A (de) 1974-03-12
MY7700075A (en) 1977-12-31
US3867423A (en) 1975-02-18
CA1041496A (en) 1978-10-31
HK75276A (en) 1976-12-10
CH596167A5 (de) 1978-02-28
CH602626A5 (de) 1978-07-31
CH595343A5 (de) 1978-02-15
ATA778173A (de) 1977-03-15
DE2344740A1 (de) 1974-03-21

Similar Documents

Publication Publication Date Title
JPS5312818A (en) Preparation of substituted chloroacetoanilide
CA1033727A (en) Preparation of w-pentanorprostaglandins
CA1020554A (en) Preparation of thiocarbamylsulfenamides
IL42255A0 (en) The preparation of cyclopropane derivatives
IL41305A0 (en) Prostaglandins and their preparation
IL41310A0 (en) The preparation of 3-carbamoyloxy-methyl cephalosphorins
ZA737995B (en) Preparation of phosphonothioureides
IL43078A0 (en) The preparation of 5-isopropyl-3-methyl-phenol
IL42995A0 (en) Difluoromethylene substituted prostaglandin derivatives and their preparation
IL42425A0 (en) 13-cis prostaglandin derivatives and their preparation
JPS5337625A (en) Preparation of substituted chloroacetoanilide
IL40101A0 (en) The preparation of certain indolobenzazepine derivatives
IL43400A0 (en) The preparation of 9-cis-tricosene
AU456371B2 (en) Prostaglandin derivatives and their preparation
AU472072B2 (en) Preparation of 3-fluoro-d-alanine
IL42381A (en) The preparation of 2-methoxy-5-alkylsulfonyl-aminoalkyl-benzamides
IL43143A0 (en) The preparation of alpha-oximinonitriles
IL42498A0 (en) The preparation of 2h-3-isoquinolones
CA1028701A (en) Preparation of thiocarbamylsulfenamides
IL42607A0 (en) Preparation of difluoro-amines
CA907016A (en) Preparation of substituted phenoxyalkylamines
CA901593A (en) Preparation of beta-halogenopropionitriles
CA913065A (en) Preparation of 21-fluoro-steroids
AU477850B2 (en) Preparation of thiocarbamylsulfenamides
AU483158B2 (en) Preparation of phosphonothioureides